美国多发性硬化患病率的种族、民族、年龄、性别和地理区域分层人群估计
该研究将验证算法应用于2008至2010年私营、军队及公共(医疗补助和医疗保险)行政理赔数据,识别成人多发性硬化病例,并结合2010年美国人口普查数据估算累积10年的患病率。结果显示,白人患病率最高,其次为黑人、非西班牙裔其他种族和西班牙裔;患病率随纬度增加而显著非均匀上升。
要点
- 2010年美国成人多发性硬化累积10年患病率:白人374.8/10万,黑人298.4/10万,西班牙裔161.2/10万,非西班牙裔其他种族197.7/10万。
- 各 race/ethnicity 组中45至64岁年龄组患病率最高,总体女性与男性比例为2.9。
- 纬度每增加1度,未调整患病率增加16.3例/10万(95%CI 12.7-19.8;P<.001),直接调整后增加11.7例/10万(95%CI 7.4-16.1;P<.001)。
核心结论
- 白人多发性硬化患病率最高,其次为黑人、非西班牙裔其他种族和西班牙裔个体;美国多发性硬化影响多种族和民族群体;患病率随纬度显著且非均匀增加,即使调整 race、ethnicity、年龄和性别后仍存在。
主要发现
- 共识别744 781名18岁及以上多发性硬化患者,其中女性564 426例(76%),男性180 355例(24%)。
- 中位年龄组为45至54岁,包含229 216人(31%);18至24岁101 271人(14%),35至44岁158 997人(21%),55至64岁186 758人(25%),65岁及以上68 539人(9%)。
- 白人577 725例(77%),黑人80 276例(10%),西班牙裔53 456例(7%),非西班牙裔其他类别33 324例(4%)。
- 2010年美国成人累积10年多发性硬化患病率:西班牙裔(不论 race)161.2/10万(95%CI 159.8-162.5),黑人298.4/10万(95%CI 296.4-300.5),白人374.8/10万(95%CI 373.8-375.8),非西班牙裔其他种族和民族组197.7/10万(95%CI 195.6-199.9)。
- 同期总体女性与男性比例为2.9;各 race 和 ethnicity 组中45至64岁年龄组患病率最高;纬度每增加1度,未调整患病率增加16.3例/10万(95%CI 12.7-19.8;P<.001),直接调整估计增加11.7例/10万(95%CI 7.4-16.1;P<.001);纬度与患病率的关联在女性、黑人和老年人中最强。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出 inconsistent racial and ethnic classifications created heterogeneity within groups。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Racial, ethnic, and geographic differences in multiple sclerosis (MS) are important factors to assess when determining the disease burden and allocating health care resources. OBJECTIVE: To calculate the US prevalence of MS in Hispanic, non-Hispanic Black (hereafter referred to as Black), and non-Hispanic White individuals (hereafter referred to as White) stratified by age, sex, and region. DESIGN, SETTING, AND PARTICIPANTS: A validated algorithm was applied to private, military, and public (Medicaid and Medicare) administrative health claims data sets to identify adult cases of MS between 2008 and 2010. Data analysis took place between 2019 and 2022. The 3-year cumulative prevalence overall was determined in each data set and stratified by age, sex, race, ethnicity, and geography. The insurance pools included 96 million persons from 2008 to 2010. Insurance and stratum-specific estimates were applied to the 2010 US Census data and the findings combined to calculate the 2010 prevalence of MS cumulated over 10 years. No exclusions were made if a person met the algorithm criteria. MAIN OUTCOMES AND MEASUREMENTS: Prevalence of MS per 100 000 US adults stratified by demographic group and geography. The 95% CIs were approximated using a binomial distribution. RESULTS: A total of 744 781 persons 18 years and older were identified with MS with 564 426 cases (76%) in females and 180 355 (24%) in males. The median age group was 45 to 54 years, which included 229 216 individuals (31%), with 101 271 aged 18 to 24 years (14%), 158 997 aged 35 to 44 years (21%), 186 758 aged 55 to 64 years (25%), and 68 539 individuals (9%) who were 65 years or older. White individuals were the largest group, comprising 577 725 cases (77%), with 80 276 Black individuals (10%), 53 456 Hispanic individuals (7%), and 33 324 individuals (4%) in the non-Hispanic other category. The estimated 2010 prevalence of MS per 100 000 US adults cumulated over 10 years was 161.2 (95% CI, 159.8-162.5) for Hispanic individuals (regardless of race), 298.4 (95% CI, 296.4-300.5) for Black individuals, 374.8 (95% CI, 373.8-375.8) for White individuals, and 197.7 (95% CI, 195.6-199.9) for individuals from non-Hispanic other racial and ethnic groups. During the same time period, the female to male ratio was 2.9 overall. Age stratification in each of the racial and ethnic groups revealed the highest prevalence of MS in the 45- to 64-year-old age group, regardless of racial and ethnic classification. With each degree of latitude, MS prevalence increased by 16.3 cases per 100 000 (95% CI, 12.7-19.8; P < .001) in the unadjusted prevalence estimates, and 11.7 cases per 100 000 (95% CI, 7.4-16.1; P < .001) in the direct adjusted estimates. The association of latitude with prevalence was strongest in women, Black individuals, and older individuals. CONCLUSIONS AND RELEVANCE: This study found that White individuals had the highest MS prevalence followed by Black individuals, individuals from other non-Hispanic racial and ethnic groups, and Hispanic individuals. Inconsistent racial and ethnic classifications created heterogeneity within groups. In the United States, MS affects diverse racial and ethnic groups. Prevalence of MS increases significantly and nonuniformly with latitude in the United States, even when adjusted for race, ethnicity, age, and sex. These findings are important for clinicians, researchers, and policy makers.
引用
- Hittle M, Culpepper WJ, Langer-Gould A, et al. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. JAMA Neurol. 2023. PMID: 37184850. doi:10.1001/jamaneurol.2023.1135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。